ArticleHematology reports2024

Complete Remission with Inotuzumab Ozogamicin as Fourth-Line Salvage Therapy in a Child with Relapsed/Refractory Acute Lymphoblastic Leukemia.

Athanasios Tragiannidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.